{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:18:26Z","timestamp":1790983106492,"version":"4.1.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,20]]},"DOI":"10.7759\/cureus.114878","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:28:11Z","timestamp":1787250491000},"source":"Crossref","is-referenced-by-count":1,"title":["Albendazole-Induced Liver Injury Mimicking Autoimmune Hepatitis"],"prefix":"10.7759","author":[{"given":"Aren","family":"Nersisyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narek","family":"Kocharyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusine","family":"Mardanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Mirumyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshak","family":"Shahenyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"US Food and Drug Administration. ALBENZA (albendazole) tablets, for oral use. Prescribing Information. (2009). Accessed: August 4, 2026: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020666s012lbl.pdf?utm_source."},{"key":"ref2","article-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","year":"2012","unstructured":"LiverTox. Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD), USA; 2012."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.04.033","article-title":"Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report","volume":"79","author":"Andrade RJ","year":"2023","unstructured":"Andrade RJ, Aithal GP, de Boer YS, et al.. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report. J Hepatol. 2023, 79:853-66. 10.1016\/j.jhep.2023.04.033","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.01.023","article-title":"Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: the answer lies at the interface","volume":"81","author":"Alkashash A","year":"2024","unstructured":"Alkashash A, Zhang X, Vuppalanchi R, Lammert C, Saxena R. Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: the answer lies at the interface. J Hepatol. 2024, 81:e45-7. 10.1016\/j.jhep.2024.01.023","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i24.2654","article-title":"Drug-induced autoimmune hepatitis: a minireview","volume":"28","author":"Tan CK","year":"2022","unstructured":"Tan CK, Ho D, Wang LM, Kumar R. Drug-induced autoimmune hepatitis: a minireview. World J Gastroenterol. 2022, 28:2654-66. 10.3748\/wjg.v28.i24.2654","journal-title":"World J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL Clinical Practice Guidelines: drug-induced liver injury","volume":"70","year":"2019","unstructured":"EASL Clinical Practice Guidelines. drug-induced liver injury. J Hepatol. 2019, 70:1222-61. 10.1016\/j.jhep.2019.02.014","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-7-201","article-title":"Albendazole-induced granulomatous hepatitis: a case report","volume":"7","author":"Marin Zuluaga JI","year":"2013","unstructured":"Marin Zuluaga JI, Marin Castro AE, Perez Cadavid JC, Restrepo Gutierrez JC. Albendazole-induced granulomatous hepatitis: a case report. J Med Case Rep. 2013, 7:201. 10.1186\/1752-1947-7-201","journal-title":"J Med Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/524266-albendazole-induced-liver-injury-mimicking-autoimmune-hepatitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:28:12Z","timestamp":1787250492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/524266-albendazole-induced-liver-injury-mimicking-autoimmune-hepatitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.114878","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}